Billerica, MA 3/14/19—Scientific instrument company Bruker has acquired Arxspan for an undisclosed amount. Arxspan provides cloud-based solutions for managing research data with a focus on the pharmaceutical biopharmaceutical industries, including ELNs.  Financial details of the transaction were not disclosed. “The Arxspan acquisition, coupled with our strategic partnership with Mestrelab, positions Bruker firmly in the field of cloud-based, scientific software for our chemistry and pharma customers,” said Dr. Falko Busse, Group President for Bruker Biospin.

Bruker has specified informatics as an area of investment for the company and future growth. Last year, Bruker purchased a 51% interest in Mestrelab (see IBO 12/15/18) for a total of $11.3 million, with an option to acquire the remainder after 2022. Based in Massachusetts and founded in 2011, Arxspan’s offerings include software for chemical and biological registration, and inventory and assay data management, giving Bruker new capabilities for lab data management and workflows. Previously, Bruker had not participated in the ELN market.